Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fujian Genohope Biotech
Putian, Fujian, China
- Ownership
- Private
- Employees
- ~250
- Development stage
- Other
01
Overview
Fujian Genohope Biotech operates a US FDA-inspected, GMP-certified facility producing commercial-scale peptide APIs, most notably semaglutide, using both synthetic and recombinant technologies, in addition to a pipeline of >50 peptide and protein drugs for metabolic and endocrine diseases[2][3][5][7].
- Therapeutic areas
- EndocrinologyCardiovascular
- Modalities
- PeptidesRecombinant proteinSmall molecule
- Industry
- Biotech
02
Partnerships
Genovior Biotech CorporationLin Yang Biotech Pharmaceutical
Beyond the preview
Go deeper on Fujian Genohope Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fujian Genohope Biotech.